Risperidone-Induced Sialorrhea: Dose-Related?

References

• 1 Allen S, Hoffer Z, Mathews M. Quetiapine-induced hypersalivation.  Prim Care Companion J Clin Psychiatry. 2007;  9 233
• 2 Berlan M, Montastruc JL, Lafontan M. Pharmacological prospects for alpha 2-adrenoceptor antagonist therapy.  Trends Pharmacol Sci. 1992;  13 277-282
• 3 Chouinard G, Margolese HC. Manual for the extrapyramidal symptom rating scale (ESRS).  Schizophr Res. 2005;  76 247-265
• 4 Fornai F, Blandizzi C, del Tacca M. Central alpha-2 adrenoceptors regulate central and peripheral functions.  Pharmacol Res. 1990;  22 541-554
• 5 Gajwani P, Franco-Bronson K, Tesar GE. Risperidone-induced sialorrhea.  Psychosomatics. 2001;  42 276
• 6 Green GJ, Wilson H, Yates MS. The mechanism of the clonidine-induced reduction in peripheral parasympathetic submaxillary salivation.  Eur J Pharmacol. 1979;  56 331-336
• 7 Hertel P, Nomikos GG, Schilstrom B. et al . Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.  Neuropsychopharmacology. 1997;  17 44-55
• 8 Kaniucki MD, Elverdin JC, Luchelli-Fortis MA. et al . Sympathetic and parasympathetic nerves regulate postsynaptic alpha-2 adrenoceptor in salivary glands.  J Pharmacol Exp Ther. 1986;  239 488-493
• 9 Megens AA, Awouters FH, Schotte A. et al . Survey on the pharmacodynamics of the new antipsychotic risperidone.  Psychopharmacology (Berl). 1994;  114 9-23
• 10 Naranjo CA, Busto U, Sellers EM. et al . A method for estimating the probability of adverse drug reactions.  Clin Pharmacol Ther. 1981;  30 239-245
• 11 Oulis P, Masdrakis VG, Karakatsanis NA. et al . Quetiapine-induced dose-dependent hypersalivation in mania.  Clin Neuropharmacol. 2009;  32 56-57
• 12 Panagiotidis PT, Fountoulakis KN, Siamouli M. et al . Risperidone-induced sialorrhea responsive to biperiden treatment.  Schizophr Res. 2007;  93 410-411

Correspondence